Table 2 Association between treatment with phosphate-binders and infection-related mortality (nā=ā2926).
Models | Unadjusted model | Model 1 | Model 2 | Model 3 | ||||
|---|---|---|---|---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | |
Use of phosphate-binders | ||||||||
Ā Ā Ā Cox proportional hazard model | 0.31 (0.21ā0.46) | <0.001 | 0.46 (0.30ā0.70) | 0.004 | 0.47 (0.31ā0.72) | 0.007 | 0.63 (0.40ā0.99) | 0.049 |
Ā Ā Ā Fine-Gray subdistribution hazards model | 0.35 (0.23ā0.52) | <0.001 | 0.53 (0.34ā0.80) | 0.003 | 0.53 (0.34ā0.82) | 0.004 | 0.64 (0.39ā1.05) | 0.078 |
Every 1āg/day increase in daily phosphate-binders dose | ||||||||
Ā Ā Ā Cox proportional hazard model | 0.61 (0.52ā0.72) | <0.001 | 0.72 (0.61ā0.85) | <0.001 | 0.72 (0.61ā0.85) | <0.001 | 0.81 (0.68ā0.97) | 0.023 |
Ā Ā Ā Fine-Gray subdistribution hazards model | 0.64 (0.54ā0.76) | <0.001 | 0.75 (0.63ā0.89) | 0.001 | 0.75 (0.63ā0.89) | 0.001 | 0.82 (0.69ā0.98) | 0.031 |